Page 37 - Read Online
P. 37
Page 8 of 13 Echarte-Morales et al. Vessel Plus 2021;5:54 https://dx.doi.org/10.20517/2574-1209.2020.105
Figure 2. (A, B) Transesophageal echocardiogram showing degenerated mitral valve bioprosthesis with severe mitral regurgitation. (C,
D) Transapical transcatheter mitral valve in valve procedure. (E, F) Transesophageal echocardiogram with final result.
Figure 3. Transcatheter mitral valve in ring procedure.
annuloplasty rings, and MR ≥ 3 was present in 76.6% of patients. Device success rate achieved was adequate
in both groups; however, technical results presented higher success in ViV group. Recurrence of significant
[43]
MR and all-cause mortality at 1 year were more frequent in ViR group . Similar results at mid-term follow
up were reported by Simonato et al. in 1079 patients (857 ViV, 222 ViR) with a mean age of 73.5 years.
[42]
Survival rate evaluated at 4 years was higher in ViV patients (62.5% vs. 49.5%), and higher residual MR was
observed in ViR group .
[42]
